Ascendis Pharma (ASND) logo

Ascendis Pharma (ASND) insider trading in the last 6 months

Form 4 filings, newest first

Quality Score today 8

2 insiders bought $777K, 3 sold $5.5M.

SellMads Bodenhoff$811KSVP & PAOat $270.19 on Sep 8, filed Sep 9
SellLars Holtug$62KDirectorat $264.13 on Sep 2, filed Sep 3
BuyJean Jacques Bienaime$270KDirectorat $245.85 on Aug 14, filed Aug 18

From SEC Form 4s, the newest filed Sep 9, 2026 · Insiders have 2 business days to file a trade

9 more filings on ASND in the last 6 months, for Pro members. See them free →

We do the work for you. Every stock is scored and ranked, every 15 seconds while the market is open. Here it's 15 minutes behind. Pro members see it live.

See all 12 tradesSee it live, free until Wednesday morning. No account. No card. Then keep going with a free account.

Pro members see every filing on ASND with what each insider bought or sold and at what price, and can turn on an optional alert when an insider buys.

Who files at Ascendis Pharma

Insider trades by person

Cluster buys at ASND

2 insiders bought ASND in the last 6 months: Jean Jacques Bienaime and Scott Thomas Smith.

Tested. Our top-⁠scored stocks returned 2.2x the average stock over the next month. How we tested it

Questions about ASND's insider trades

As of Nov 2, 2026: Ascendis Pharma (ASND) has 12 insider filings on record in the last 6 months, the newest filed Sep 9, 2026. Its Quality Score is 8 (Average). Scores as of 10:25 PM ET, 15 minutes behind.

Are ASND insiders buying or selling?

2 insiders bought $777K across 9 filings, and 3 insiders sold $5.5M across 3 filings, in the last 6 months. The newest filing: Mads Bodenhoff, SVP & PAO, sold $811K on Sep 8, 2026. 2 insiders bought ASND in the last 6 months: Jean Jacques Bienaime and Scott Thomas Smith.

Who are ASND's biggest insider sellers?

By the dollars of their sales in the last 6 months: Flemming Steen Jensen (Insider), 1 sale; Mads Bodenhoff (SVP & PAO), 1 sale; Lars Holtug (Director), 1 sale.

When did an ASND insider last buy?

Jean Jacques Bienaime, Director, bought ASND shares ($270K) on Aug 14, 2026, filed Aug 18, 2026, the newest insider buy on record.

Ascendis Pharma's page has its Quality Score, its chart, and its earnings. More in Healthcare and Biotech. ASND is on insider buys, Aug 17 to 23, 2026.

Shares insiders bought or sold themselves, as filed on Form 4. Grants, option exercises, shares withheld for tax, and 10b5-1 plan sales are left out.

Our top-scored stocks' record: Oct 2021 to Sep 2026, before costs. Recorded live since Sep 9 2026.

Breakaway publishes impersonal securities research and analytical tools: one formula, the same score for everyone. It is not personalized investment advice, and nothing here is a recommendation to buy or sell any security.

Market data from a licensed vendor. The age of every quote is shown on the page.

This browser is too old to show this page right. Update it, or open this page in Safari or Chrome.